Clinical Research Directory
Browse clinical research sites, groups, and studies.
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Sponsor: Zagazig University
Summary
To follow up the efficacy and safety of Candida antigen, bivalent HPV vaccine in treatment of common warts either mono or combined intralesional therapy
Official title: Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts: Monotherapy Versus Combined Therapy
Key Details
Gender
All
Age Range
9 Years - Any
Study Type
INTERVENTIONAL
Enrollment
162
Start Date
2022-04-03
Completion Date
2025-12-06
Last Updated
2025-06-12
Healthy Volunteers
No
Conditions
Interventions
Candida antigen vaccine
we will study the efficacy and safety of agent in the treatment of multiple warts, we will follow up the recurrence rate of each group
Bivalent HPV vaccine
we will study the efficacy and safety of agent in the treatment of multiple warts, we will follow up the recurrence rate of each group
Locations (1)
Reham Essam
Zagazig, Al Sharqia, Egypt